Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatment.
- 12 July 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Neurology and Neuroscience Reports
- Vol. 7 (4), 302-310
- https://doi.org/10.1007/s11910-007-0046-y
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Motor fluctuations and dyskinesias in advanced/end stage Parkinson’s disease: a study from a population of brain donorsJournal of Neural Transmission, 2006
- In 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Primates, the Selective 5-Hydroxytryptamine 1a Agonist (R)-(+)-8-OHDPAT Inhibits Levodopa-Induced Dyskinesia but Only with\ Increased Motor DisabilityJournal of Pharmacology and Experimental Therapeutics, 2006
- Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopaMovement Disorders, 2006
- Efficacy and Tolerability of Levetiracetam in Parkinson Disease Patients With Levodopa-Induced DyskinesiaClinical Neuropharmacology, 2006
- Docosahexaenoic acid reduces levodopa‐induced dyskinesias in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine monkeysAnnals of Neurology, 2006
- Open‐label pilot study of levetiracetam (Keppra) for the treatment of levodopa‐induced dyskinesias in Parkinson's diseaseMovement Disorders, 2005
- Parkinson's disease home diary: Further validation and implications for clinical trialsMovement Disorders, 2004
- Dyskinesia after fetal cell transplantation for parkinsonism: A PET studyAnnals of Neurology, 2002
- Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum: A prospective randomized comparisonMovement Disorders, 1999
- Suppression of dyskinesias in advanced Parkinson's disease: Moderate daily clozapine doses provide long‐term dyskinesia reductionMovement Disorders, 1994